BIOSTA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 63,115 | 73,366 | 291,581 | 567,062 | 1,416,613 | 50,837 | 36,937 | 51,155 |
| Profit before tax | 768 | 22,579 | 119,265 | 172,816 | 118,095 | 342,189 | -15,452 | 6,613 |
| Net profit | 730 | 21,450 | 112,841 | 146,874 | 46,693 | 342,189 | -15,452 | 6,613 |
| Equity | 56,548 | 77,997 | 190,837 | 337,711 | 384,404 | 726,593 | 711,139 | 717,751 |
| Liabilities | 22,375 | 23,715 | 9,746 | 122,242 | 488,727 | 11,993 | 9,749 | 8,657 |
| Non-current assets | 19,502 | 12,077 | 70,261 | 199,129 | 199,311 | - | 177,685 | 162,898 |
| Current assets | 58,033 | 87,317 | 129,231 | 260,051 | 672,851 | 547,503 | 542,555 | 562,755 |
| Total assets | 77,535 | 99,394 | 199,492 | 459,180 | 872,162 | 547,503 | 720,240 | 725,653 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 121,042 | 215 | 210 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +64.9% | +16.2% | +297.4% | +94.5% | +149.8% | -96.4% | -27.3% | +38.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.9% | 21.6% | 56.6% | 32.0% | 5.4% | 62.5% | -2.1% | 0.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.3% | 27.5% | 59.1% | 43.5% | 12.1% | 47.1% | -2.2% | 0.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.2% | 29.2% | 38.7% | 25.9% | 3.3% | 673.1% | -41.8% | 12.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.2% | 30.8% | 40.9% | 30.5% | 8.3% | 673.1% | -41.8% | 12.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.3 | 0.1 | 0.4 | 1.3 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 31,558 | 36,683 | 145,791 | 194,419 | 404,747 | 16,946 | 17,730 | 25,578 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIOSTA - Social security debts
The company had no debts to Sodra
BIOSTA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIOSTA, UAB (code 302332449) is a Private Limited Liability Company engaged in research and development in natural sciences. In 2025, the company generated revenue of €51.2K, up 38.5% year on year, and returned to profitability with net profit of €6.6K, compared with a loss of €15.5K in 2024. Over the two-year period, revenue was broadly stable, increasing by 0.6% versus 2023, while profit moved from a very strong result in 2023 to a loss in 2024 and then back to a modest gain in 2025. The 2025 profit margin was 12.9%. The balance sheet remained conservative: total assets were €725.7K, equity €717.8K, and liabilities only €8.7K. This corresponds to an equity ratio of 98.9% and a debt-to-equity ratio of 0.01. Returns remained low, with ROE and ROA both at 0.9%, and asset turnover at 0.07x, indicating limited revenue generation relative to asset base. Revenue per employee was €25.6K and profit per employee €3.3K.